Ultibro Breezhaler (Indacaterol/Glycopyrronium Bromide)

Name: Ultibro Breezhaler
Brand: Novartis
SKU: 6978
Availability: InStock

Type

Product

Manufacturer

Country

Dosage

Qty-Price (USD)

Type:

Product: Ultibro Breezhaler 3 x 10 Capsules

Manufacturer: Novartis

Country: Canada

Dosage: 110 mcg/50 mcg

Qty-Price (USD):

Generic Equivalent of Ultibro Breezhaler

Type

Product

Manufacturer

Country

Dosage

Qty-Price (USD)

There is no generic product of Ultibro Breezhaler.

Ultibro Breezhaler Information

medically reviewed by Dr. HaVy Ngo, Pharmacist on May 1, 2026.

Ultibro Breezhaler at CanadaPharmacyOnline.com

The manufacturer of brand-name Ultibro Breezhaler is Novartis Pharmaceuticals Canada Inc. Ultibro is a high-performance, once-daily dual bronchodilator delivered via the Breezhaler device, which allows patients to see, hear, and taste that they have taken the medication correctly.

There is currently no generic version of Ultibro Breezhaler available.

Dosage:

Ultibro Breezhaler is available in a standard fixed-dose strength:
• Capsules: 110 mcg of indacaterol (as maleate) and 50 mcg of glycopyrronium (as bromide) per capsule.

The dosage is one capsule inhaled once daily at the same time each day. The medication is contained in capsules that are placed into the Breezhaler device. Do not swallow the capsules. Each pack comes with a new Breezhaler device. Always use the inhaler provided with your current prescription.

Usage:

Ultibro Breezhaler is indicated for the long-term maintenance treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is used to reduce symptoms like shortness of breath and to prevent periodic worsening (exacerbations). It is not approved for the treatment of asthma.

Mechanism of Action
Ultibro works by combining two long-acting bronchodilators to maximize lung function. Indacaterol is a long-acting beta2-agonist. It works by stimulating receptors in the airway muscles, causing them to relax and stay open for a full 24 hours. Glycopyrronium is a long-acting muscarinic antagonist (anticholinergic). It works by blocking the signals (acetylcholine) that cause the muscles around the airways to tighten. By relaxing the muscles and preventing them from tightening simultaneously, Ultibro provides more significant airflow improvement than either medication used alone.

Take Ultibro Breezhaler exactly as your doctor prescribes, according to the consumer medicine information. Ultibro should be taken once daily at the same time every day, regardless of whether you have symptoms.

The information below summarizes some, but not all, potential side effects, risks, and interactions. Before starting Ultibro Breezhaler, it is essential to discuss all possible side effects, risks, and interactions with your doctor or pharmacist.

Side Effects:

The information below outlines potential side effects of Ultibro Breezhaler (indacaterol/glycopyrronium bromide). It is not an exhaustive list, and individual reactions can vary.

Common side effects: These are common side effects of Ultibro Breezhaler; other side effects are possible. Contact your doctor promptly if any side effects are persistent, worsening, or concerning, or if you experience any other concerning symptoms.
• Cough
• Sore throat
• Dizziness
• Headache
• Dry mouth
• Muscle or joint pain
• Nausea

Serious Side Effects: Seek immediate medical attention or call emergency services if you experience any of the following symptoms:
• Glaucoma: Eye pain, blurred vision, or seeing "halos" around lights.
• Heart Problems: Fast or irregular heartbeat, palpitations, or chest pain.
• Paradoxical Bronchospasm: Sudden, severe wheezing or trouble breathing immediately after use.
• Urinary Issues: Difficulty or pain when urinating (signs of urinary retention).

Contraindications:

The following is not an exhaustive list of contraindications. Before starting Ultibro Breezhaler, it is crucial to discuss all your medical conditions, past and present, and all medications you are taking with your doctor or pharmacist.

Do not take Ultibro Breezhaler/indacaterol/glycopyrronium bromide if:
• Allergies: You have a known hypersensitivity to indacaterol, glycopyrronium bromide, or any of the medication's ingredients.
• Asthma: Ultibro is not for asthma. LABAs without a steroid in asthma patients increase the risk of serious complications.
• Milk Protein Allergy: The capsules contain lactose, which may have traces of milk protein.

Tell your doctor about all of your medical conditions, past and present, before starting Ultibro Breezhaler. This is crucial as certain conditions affect the drug's safety.
• Heart Conditions: Use with caution if you have a history of heart rhythm problems or high blood pressure.
• Prostate or Bladder Issues: The anticholinergic component can worsen urinary retention.

Drug Interactions:

Before taking Ultibro Breezhaler, discuss all potential risks and interactions with your doctor or pharmacist. For complete and up-to-date information, please visit the product monograph at https://pdf.hres.ca/dpd_pm/00072513.PDF.

Provide your doctor with a complete list of all your medications, including prescriptions, over-the-counter (OTC) drugs, vitamins, herbal supplements, recreational drugs, and any significant dietary changes, as these may interact with Ultibro Breezhaler. Ultibro Breezhaler may interact with other medicines, including but not limited to:
• Beta-Blockers: These can block the LABA component, leading to airway tightening.
• Other Anticholinergics/LABAs: Do not use with other LAMA or LABA medications (e.g., Spiriva or Serevent), as this increases the risk of side effects.
• Potassium-Lowering Drugs: Certain diuretics may increase the risk of low potassium levels.

Pregnancy and Breastfeeding:

Ultibro should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is unknown if the ingredients pass into breast milk. Consult your doctor to weigh the risks to the infant versus the importance of the drug to the mother.

Use in Children:

Ultibro Breezhaler is not approved for use in children or adolescents under 18 years of age.

Frequently Asked Questions about Ultibro Breezhaler at Canada Pharmacy Online

Why is Ultibro Breezhaler more affordable in Canada than in the United States?

Prescription drug prices, including Ultibro Breezhaler, are generally lower in Canada than in the U.S. due to a combination of factors, primarily government price regulations, differing market dynamics, and other economic considerations. In Canada, provincial and federal governments negotiate drug prices with pharmaceutical companies, which often results in lower prices than in the U.S., where market forces play a more significant role. For more information, see the FAQs on Prescription Drug Importation from the Kaiser Family Foundation (KFF): https://www.kff.org/health-costs/issue-brief/faqs-on-prescription-drug-importation/

How much is the shipping?

Our shipping fee is a flat rate of $10.00 per order. Our pharmacy is dedicated to offering you the lowest prices on high-quality products.

How do I place an order with your pharmacy?

Ordering from us is very simple. You can purchase online or call Customer Service at 1866.920.3784; for more information or to learn about the ordering process, visit our How to Order page.

Is there a limit on how many Ultibro Breezhaler I can order at once?

CanadaPharmacyOnline.com can dispense up to a three-month supply of Ultibro Breezhaler per prescription from your doctor.

Can I buy Ultibro Breezhaler from you over the counter?

No, Ultibro Breezhaler requires a valid prescription from your doctor. We do not sell this product without a valid prescription.

Do you ship to the United States?

Yes, we do. It usually takes between 7 and 18 business days to receive your order from our pharmacy.

Is there a generic for Ultibro Breezhaler?

No, the generic indacaterol/glycopyrronium bromide is currently unavailable (at this pharmacy).

Blog Post:

Ellipta for COPD or Asthma? What You Should Know

Latest News:

Climate change is making outdoors challenging for people with asthma (news published on April 20, 2026)

Similar Drugs in the category of Asthma Medication/ Respiratory Disorders:

Flovent Inhaler Advair Symbicort Inhalation Aerosol Spiriva Caps and Device Albuterol

The information on this page is sourced from independent third parties contracted by CanadaPharmacyOnline. While we cannot guarantee its medical accuracy, we strongly recommend consulting a healthcare professional for personalized advice regarding medications or medical conditions.

Reviews From Real Customers